HIV-1 gp120: A Target for Therapeutics and Vaccine Design

Author(s): Claudia Cicala, Fatima Nawaz, Katija Jelicic, James Arthos and Anthony S. Fauci

Volume 17, Issue 1, 2016

Page: [122 - 135] Pages: 14

DOI: 10.2174/1389450116666150825120735

Price: $65

Abstract

Although extraordinary progress has been made in the treatment and prevention of HIV infection, the AIDS pandemic continues to rage globally with 2.1 million infections and 1.6 million AIDS-related deaths reported in 2013. Until an effective vaccine is developed, new strategies for treatment and prevention are needed. Regarding the prevention of HIV infection, a major focus of prevention research in general and vaccine research in particular involves the interaction of the HIV-1 envelope protein gp120 with cell-surface receptors, with the hope that a greater understanding of these interactions will lead to the development of novel strategies aimed at preventing and even treating HIV-1 infection. Particular attention has been directed toward gaining a more precise understanding of the early events in transmission focusing on that critical window of time when HIV first establishes infection in the host. Here we describe some of the recent findings involving HIV-1 envelope interactions with cell surface receptors that are relevant to transmission and which may represent new opportunities to develop strategies to prevent HIV infection.

Keywords: HIV-1, gp120, transmission, signal transduction, integrin, α4β7.

Graphical Abstract


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy